CDKN2A and meningioma: We also performed p16 immunohistochemistry on 14 CNS WHO grade 1 meningiomas that were all confirmed by DNA sequencing to have intact/wildtype CDKN2A alleles (Supplementary Table 2 [Online Resource 1]).